{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:20:12Z","timestamp":1788315612585,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":70,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030592608","type":"print"},{"value":"9783030592615","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-59261-5_3","type":"book-chapter","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T14:02:56Z","timestamp":1614780176000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection"],"prefix":"10.1007","author":[{"given":"Genevieve","family":"Mezoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2307\/1588476","volume":"14","author":"T Estola","year":"1970","unstructured":"Estola T (1970) Coronaviruses, a new group of animal RNA viruses. Avian Dis 14:330\u2013336","journal-title":"Avian Dis"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/JCM.36.2.539-542.1998","volume":"36","author":"MJ M\u00e4kel\u00e4","year":"1998","unstructured":"M\u00e4kel\u00e4 MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpim\u00e4ki M et al (1998) Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 36:539\u2013542","journal-title":"J Clin Microbiol"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten C, G\u00fcnther S, Preiser W, Van Der Werf S, Brodt HR, Becker S et al (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967\u20131976","journal-title":"N Engl J Med"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814\u20131820","journal-title":"N Engl J Med"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507\u2013513","journal-title":"Lancet"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71:762\u2013768","journal-title":"Clin Infect Dis"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","volume":"35","author":"F Jiang","year":"2020","unstructured":"Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z (2020) Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 35:1545\u20131549","journal-title":"J Gen Intern Med"},{"key":"3_CR8","unstructured":"WHO (2020) WHO Coronavirus Disease (COVID-19) Dashboard [Online]. Available: https:\/\/covid19.who.int\/. Accessed 23rd July 2020"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nri1732","volume":"5","author":"S Perlman","year":"2005","unstructured":"Perlman S, Dandekar AA (2005) Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 5:917\u2013927","journal-title":"Nat Rev Immunol"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273","journal-title":"Nature"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","volume":"41","author":"S Jiang","year":"2020","unstructured":"Jiang S, Hillyer C, Du L (2020) Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol 41:355\u2013359","journal-title":"Trends Immunol"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2007.11.002","volume":"197","author":"G Brevetti","year":"2008","unstructured":"Brevetti G, Schiano V, Chiariello M (2008) Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis 197:1\u201311","journal-title":"Atherosclerosis"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418","journal-title":"Lancet"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","volume":"30","author":"D Klein","year":"1999","unstructured":"Klein D, Hurley LB, Quesenberry JC (1999) Sidney S (2002) Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 30:471\u2013477","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091063","volume":"9","author":"T Wang","year":"2014","unstructured":"Wang T, Green LA, Gupta SK, Kim C, Wang L, Almodovar S et al (2014) Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction. PLoS One 9:e91063. https:\/\/doi.org\/10.1371\/journal.pone.0091063","journal-title":"PLoS One"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/JVI.76.1.427-431.2002","volume":"76","author":"C-H Chang","year":"2002","unstructured":"Chang C-H, Huang Y, Issekutz AC, Griffith M, Lin K-H, Anderson R (2002) Interleukin-1\u03b1 released from epithelial cells after adenovirus type 37 infection activates intercellular adhesion molecule 1 expression on human vascular endothelial cells. J Virol 76:427\u2013431","journal-title":"J Virol"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5830\/CVJA-2010-056","volume":"22","author":"C Fourie","year":"2011","unstructured":"Fourie C, Van Rooyen J, Pieters M, Conradie K, Hoekstra T, Schutte A (2011) Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa? Cardiovasc J Afr 22:134\u2013140","journal-title":"Cardiovasc J Afr"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1293.2012.01027.x","volume":"14","author":"H Arildsen","year":"2013","unstructured":"Arildsen H, Sorensen KE, Ingerslev JM, Ostergaard LJ, Laursen AL (2013) Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy. HIV Med 14:1\u20139","journal-title":"HIV Med"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1086\/597475","volume":"199","author":"MG Van Vonderen","year":"2009","unstructured":"Van Vonderen MG, Hassink EA, Van Agtmael MA, Stehouwer CD, Danner SA, Reiss P et al (2009) Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy. J Infect Dis 199:1186\u20131194","journal-title":"J Infect Dis"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s10096-018-3370-z","volume":"37","author":"N Hemmat","year":"2018","unstructured":"Hemmat N, Ebadi A, Badalzadeh R, Memar MY, Baghi HB (2018) Viral infection and atherosclerosis. J Clin Microbiol Infect Dis 37:2225\u20132233","journal-title":"J Clin Microbiol Infect Dis"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11239-011-0662-x","volume":"33","author":"M Popovi\u0107","year":"2012","unstructured":"Popovi\u0107 M, Smiljani\u0107 K, Dobutovi\u0107 B, Syrovets T, Simmet T, Isenovi\u0107 ERJJOT et al (2012) Human cytomegalovirus infection and atherothrombosis. J Thromb Thrombolysis 33:160\u2013172","journal-title":"J Thromb Thrombolysis"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/qjmed\/hcy305","volume":"112","author":"A Peretz","year":"2019","unstructured":"Peretz A, Azrad M, Blum A (2019) Influenza virus and atherosclerosis. QJM 112:749\u2013755","journal-title":"QJM"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00281-017-0637-x","volume":"39","author":"CF Basler","year":"2017","unstructured":"Basler CF (2017) Molecular pathogenesis of viral hemorrhagic fever. Semin Immunopathol 39:551\u2013561","journal-title":"Semin Immunopathol"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","volume":"70","author":"H Feldmann","year":"1996","unstructured":"Feldmann H, Bugany H, Mahner F, Klenk H-D, Drenckhahn D, Schnittler HJ (1996) Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages. J Virol 70:2208\u20132214","journal-title":"J Virol"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1086\/425016","volume":"190","author":"J Ter Meulen","year":"2004","unstructured":"Ter Meulen J, Sakho M, Koulemou K, Magassouba NF, Bah A, Preiser W et al (2004) Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis 190:1821\u20131827","journal-title":"J Infect Dis"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","volume":"13","author":"M Rastogi","year":"2016","unstructured":"Rastogi M, Sharma N, Singh SK (2016) Flavivirus NS1: a multifaceted enigmatic viral protein. Virol J 13:131\u2013131","journal-title":"Virol J"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E (2015) Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med 7:304ra141. https:\/\/doi.org\/10.1126\/scitranslmed.aaa3787","journal-title":"Sci Transl Med"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1590\/0074-02760160085","volume":"111","author":"L Noronha","year":"2016","unstructured":"Noronha L, Zanluca C, Azevedo ML, Luz KG, Santos CN (2016) Zika virus damages the human placental barrier and presents marked fetal neurotropism. Mem Inst Oswaldo Cruz 111:287\u2013293","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120\u2013128","journal-title":"N Engl J Med"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271\u2013280","journal-title":"Cell"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis M, Lely A, Navis G, Van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637","journal-title":"J Pathol"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450\u2013454","journal-title":"Nature"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DH, M\u00fcller MA, Dijkman R et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251\u2013254","journal-title":"Nature"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/357420a0","volume":"357","author":"CL Yeager","year":"1992","unstructured":"Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT et al (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420\u2013422","journal-title":"Nature"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1128\/JVI.02615-14","volume":"89","author":"F Li","year":"2015","unstructured":"Li F (2015) Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol 89:1954\u20131964","journal-title":"J Virol"},{"key":"3_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110230","volume":"127","author":"M Zhao","year":"2020","unstructured":"Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z et al (2020) Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 127:110230. https:\/\/doi.org\/10.1016\/j.biopha.2020.110230","journal-title":"Biomed Pharmacother"},{"key":"3_CR37","doi-asserted-by":"publisher","unstructured":"Tong M, Jiang Y, Xia D, Xiong Y, Zheng Q, Chen F et al (2020) Elevated serum endothelial cell adhesion molecules expression in COVID-19 patients. J Infect Dis:jiaa349. https:\/\/doi.org\/10.1093\/infdis\/jiaa349","DOI":"10.1093\/infdis\/jiaa349"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","volume":"190","author":"R Escher","year":"2020","unstructured":"Escher R, Breakey N, L\u00e4mmle BJTR (2020) Severe COVID-19 infection associated with endothelial activation. Thromb Res 190:62. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.014","journal-title":"Thromb Res"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-030-12668-1_11","volume":"1134","author":"G Mezoh","year":"2019","unstructured":"Mezoh G, Crowther NJ (2019) Deciphering endothelial dysfunction in the HIV-infected population. Adv Exp Med Biol 1134:193\u2013215","journal-title":"Adv Exp Med Biol"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","volume":"67","author":"JE Sadler","year":"1998","unstructured":"Sadler JE (1998) Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67:395\u2013424","journal-title":"Annu Rev Biochem"},{"key":"3_CR41","first-page":"72","volume":"14","author":"JM Munro","year":"1993","unstructured":"Munro JM (1993) Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur Heart J 14:72\u201377","journal-title":"Eur Heart J"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jmv.20007","volume":"72","author":"P Koraka","year":"2004","unstructured":"Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD et al (2004) Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol 72:445\u2013450","journal-title":"J Med Virol"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/10623320600972135","volume":"13","author":"JE Cardier","year":"2006","unstructured":"Cardier JE, Rivas B, Romano E, Rothman AL, Perez-Perez C, Ochoa M et al (2006) Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 13:335\u2013340","journal-title":"Endothelium"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","volume":"24","author":"H Umehara","year":"2004","unstructured":"Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T (2004) Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24:34\u201340","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1002\/ajh.25881","volume":"95","author":"ME Nizzoli","year":"2020","unstructured":"Nizzoli ME, Merati G, Tenore A, Picone C, Consensi E, Perotti L et al (2020) Circulating endothelial cells in COVID-19. Am J Hematol 95:E187\u2013E188. https:\/\/doi.org\/10.1002\/ajh.25881","journal-title":"Am J Hematol"},{"key":"3_CR46","doi-asserted-by":"publisher","unstructured":"Khider L, Gendron N, Goudot G, Chocron R, Hauw-Berlemont C, Cheng C et al (2020) Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14968","DOI":"10.1111\/jth.14968"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1160\/TH04-09-0578","volume":"93","author":"AD Blann","year":"2005","unstructured":"Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM et al (2005) Circulating endothelial cells. Thromb Haemost 93:228\u2013235","journal-title":"Thromb Haemost"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1089\/aid.2011.0152","volume":"28","author":"M L\u00f3pez","year":"2012","unstructured":"L\u00f3pez M, Vispo E, San Rom\u00e1n J, Herrero D, Peris A, Corral A et al (2012) High risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells. AIDS Res Hum Retrov 28:656\u2013659","journal-title":"AIDS Res Hum Retrov"},{"key":"3_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102763","volume":"55","author":"J Liu","year":"2020","unstructured":"Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102763","journal-title":"EBioMedicine"},{"key":"3_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li J-W, Zhao H, Wang GQ (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 55:105954. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"L-A Teuwen","year":"2020","unstructured":"Teuwen L-A, Geldhof V, Pasut A, Carmeliet P (2020) COVID-19: the vasculature unleashed. Nat Rev Immunol 20:389\u2013391","journal-title":"Nat Rev Immunol"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089\u20131098","journal-title":"Intensive Care Med"},{"key":"3_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1996","volume":"369","author":"MG Argenziano","year":"2020","unstructured":"Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG et al (2020) Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 369:m1996. https:\/\/doi.org\/10.1136\/bmj.m1996","journal-title":"BMJ"},{"key":"3_CR54","doi-asserted-by":"publisher","unstructured":"Atkins JL, Masoli JA, Delgado J, Pilling LC, Kuo C-L, Kuchel GA et al (2020) Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontol A Biol Sci Med Sci:glaa183. https:\/\/doi.org\/10.1093\/gerona\/glaa183","DOI":"10.1093\/gerona\/glaa183"},{"key":"3_CR55","doi-asserted-by":"publisher","unstructured":"Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.4683","DOI":"10.1001\/jama.2020.4683"},{"key":"3_CR56","doi-asserted-by":"publisher","unstructured":"Davies MA (2020) HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. medRxiv:20145185. https:\/\/doi.org\/10.1101\/2020.07.02.20145185","DOI":"10.1101\/2020.07.02.20145185"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2019.08.011","volume":"30","author":"X Li","year":"2019","unstructured":"Li X, Sun X, Carmeliet P (2019) Hallmarks of endothelial cell metabolism in health and disease. Cell Metab 30:414\u2013433","journal-title":"Cell Metab"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1210\/er.2019-00002","volume":"40","author":"MY Donath","year":"2019","unstructured":"Donath MY, Meier DT, B\u00f6ni-Schnetzler M (2019) Inflammation in the pathophysiology and therapy of cardiometabolic disease. Endocr Rev 40:1080\u20131091","journal-title":"Endocr Rev"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom8030080","volume":"8","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X et al (2018) Research progress on the relationship between atherosclerosis and inflammation. Biomol Ther 8:80. https:\/\/doi.org\/10.3390\/biom8030080","journal-title":"Biomol Ther"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"E2095","DOI":"10.3390\/jcm9072095","volume":"9","author":"M Vinciguerra","year":"2020","unstructured":"Vinciguerra M, Romiti S, Fattouch K, De Bellis A, Greco E (2020) Atherosclerosis as pathogenetic substrate for Sars-Cov-2 cytokine storm. J Clin Med 9:E2095. https:\/\/doi.org\/10.3390\/jcm9072095","journal-title":"J Clin Med"},{"key":"3_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09536-z","volume":"7","author":"Q Wu","year":"2017","unstructured":"Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J et al (2017) Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 7:9110. https:\/\/doi.org\/10.1038\/s41598-017-09536-z","journal-title":"Sci Rep"},{"key":"3_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2648","volume":"370","author":"RM Johnson","year":"2020","unstructured":"Johnson RM, Vinetz JM (2020) Dexamethasone in the management of COVID-19. BMJ 370:m2648. https:\/\/doi.org\/10.1136\/bmj.m2648","journal-title":"BMJ"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","volume":"92","author":"P Luo","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol 92:814\u2013818","journal-title":"J Med Virol"},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A 117:10970\u201310975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejim.2020.05.011","volume":"76","author":"V Morena","year":"2020","unstructured":"Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C et al (2020) Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med 76:36\u201342","journal-title":"Eur J Intern Med"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","volume":"395","author":"M Feldmann","year":"2020","unstructured":"Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M et al (2020) Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet 395:1407\u20131409","journal-title":"Lancet"},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ijid.2020.05.115","volume":"96","author":"KC Lee","year":"2020","unstructured":"Lee KC, Sewa DW, Phua GC (2020) Potential role of statins in COVID-19. Int J Infect Dis 96:615\u2013617","journal-title":"Int J Infect Dis"},{"key":"3_CR68","doi-asserted-by":"publisher","unstructured":"Fedson D, Opal S, Rordam OM (2020) Treating patients with severe COVID-19 infection. mBio 11:e00398\u2013e00320. doi:https:\/\/doi.org\/10.1128\/mBio.00398-20","DOI":"10.1128\/mBio.00398-20"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"AHJ Danser","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic. At present there is no evidence to abandon renin-angiotensin system blockers. Hypertension 75:1382\u20131385","journal-title":"Hypertension"},{"key":"3_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03062-7","volume":"24","author":"S Pons","year":"2020","unstructured":"Pons S, Fodil S, Azoulay E, Zafrani L (2020) The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 24:353. https:\/\/doi.org\/10.1186\/s13054-020-03062-7","journal-title":"Crit Care"}],"container-title":["Advances in Experimental Medicine and Biology","Clinical, Biological and Molecular Aspects of COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-59261-5_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T19:04:18Z","timestamp":1675019058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-59261-5_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030592608","9783030592615"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-59261-5_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"4 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}